{"id":"W2897241170","doi":"10.1182/blood-2018-06-858852","title":"Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University","funders":"Karyopharm Therapeutics","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Carfilzomib; Medicine; Refractory (planetary science); Oncology; Internal medicine; Pomalidomide; Lenalidomide; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000456411,0.000433617,0.000884022,0.0002071196,0.0002252915,0.0003105575,0.0002333627,0.0002545517,0.0009701797],"category_scores_gemma":[0.0003801564,0.0001373528,0.0004788848,0.00020774,0.0001863494,0.000271882,0.0001934897,0.0006470753,0.0002419976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004001954,"about_ca_system_score_gemma":0.0004124459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000346184,"about_ca_topic_score_gemma":0.001269004,"domain_scores_codex":[0.9998511,0.00006320563,0.00001515564,0.00002479104,0.00002011165,0.00002565115],"domain_scores_gemma":[0.9998208,0.00003530925,0.00004549415,0.000009222498,0.000008543697,0.00008063996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1554766,0.01180377,0.2073947,0.001105307,0.001302585,0.003927486,0.0005967392,0.005119047,0.1121317,0.0003369073,0.006734776,0.4940704],"study_design_scores_gemma":[0.07091654,0.3711179,0.5004501,0.0002504599,0.001078027,0.00728372,0.0004334234,0.00922648,0.02233136,0.0006340381,0.01619438,0.00008367447],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962924,0.002378945,0.0001739903,0.0002182553,0.00002022109,0.0001174249,0.0001170771,0.00003079272,0.0006508169],"genre_scores_gemma":[0.9981791,0.0006569974,0.0003569101,0.0002239616,0.00003555032,0.00005741655,0.000169142,0.000003000318,0.0003179669],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009701797,"threshold_uncertainty_score":0.003245592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02251411635390486,"score_gpt":0.2883741098069045,"score_spread":0.2658599934529997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}